Connect with us

coronavirus

Learn about how COVID-19 vaccines are approved in the EU in online event with experts from the European Medicines Agency  

SHARE:

Published

6 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Today (11 December), the European Medicines Agency (EMA) will hold an online event to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA's specific role. It will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns, that will be considered by EMA and the European medicines regulatory network in the decision-making process. The event will start at 13h CET and can be followed online.

More information is available on the new Commission website on safe and effective vaccination in the EU. In particular, learn about how vaccines work, the health benefits of vaccines, the authorization process, their long-term safety and the EU's current portfolio.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending